Concepedia

Determination of alendronate in low volumes of plasma by column-switching high-performance liquid chromatography method and its application to pharmacokinetic studies in human plasma

Eunmi Ban, Ji-Youn Park, Hyungtae Kim, Chong‐Kook Kim

Archives of Pharmacal Research · 2011 · 14 citations · 20 references

DOI

Concepts

References

20

Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age

David Hosking, Clair E.D. Chilvers, Claus Christiansen et al. · New England Journal of Medicine · 1998 · 487 citations · Full text

, , +17

Prevention of Bone Loss With Alendronate in Postmenopausal Women Under 60 Years of Age

David Hosking, Clair Chilvers, Claus Christiansen et al. · Obstetrical & Gynecological Survey · 1998 · 211 citations

, , +17

Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals.

J H Lin, D E Duggan, I W Chen et al. · Drug Metabolism and Disposition · 1991 · 161 citations

, , +9

Clodronate kinetics and bioavailability

Gerald J. Yakatan, Wesley J. Poynor, Robert L. Talbert et al. · Clinical Pharmacology & Therapeutics · 1982 · 119 citations

, , +17

Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats.

Jiunn H. Lin, I W Chen, D E Duggan · Drug Metabolism and Disposition · 1992 · 98 citations

, , +7